La cadena de opciones muestra datos clave de las opciones de acciones de KSB SE & Co a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para KSB SE & Co..

KSB SE & Co (OTC:KSVRF) Bolsa, Cadena de Opciones

KSB SE & Co KGaA is a German-based company. It is a provider of pumps, valves, and related services. Its operations are carried out in three segments namely Pumps, Valves, and KSB SupremeServ Segment comprises the spare parts business for pumps and valves. A majority part of its sales and revenue is comes from the Pumps segment. The Pumps segment includes single and multistage pumps, submersible pumps, and associated control and drives systems. The company's pumps are used in various applications where fluids need to be transported as well as in other applications which belong to industry, building services, water engineering, wastewater engineering, energy supply, and mining.

KSB SE & CO KGAA PREF RTS by KSB SE & CO.

KSB SE & Co KGaA

Food company Pilgrim&#8217;s Pride Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPC#NASDAQ">PPC</a>) shares are <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">trading higher in premarket</a> on Friday.
The company has introduced a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44323543/pilgrims-announces-1-5-billion-special-dividend-and-long-term-capital-allocation-strategy" rel="noreferrer noopener">capital allocation strategy </a>designed to strengthen its financial position, broaden its diverse portfolio, and generate long-term value for its shareholders.
As a component of this initiative, the board has approved a special cash dividend of $6.30 per share. With the current share count, the total special dividend payout is approximately $1.5 billion.
This payment will be made on April 17, 2025, to shareholders on record as of April 3, 2025.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/03/44305204/metas-community-notes-to-replace-third-party-fact-checkers" rel="noreferrer noopener">Meta&#8217;s Community Notes To Replace Third-Party Fact Checkers</a>
&#8220;Pilgrim&#8217;s is confident in the future of our business and we believe our capital allocation strategy positions the company for continued, disciplined growth and enhanced earnings potential across our diversified portfolio,&#8221; said CEO Fabio Sandri.
&#8220;The Board&#8217;s decision to pay a special dividend reflects our strong balance sheet and our commitment to create long-term stockholder value.&#8221;
In addition to the dividend, Pilgrim&#8217;s Pride has outlined steps to further strengthen its business operations.
The company is focusing on key areas such as expanding its prepared foods segment, increasing small bird production for key customer demands, and transforming a major bird facility into a case-ready plant to support retail growth.
Furthermore, Pilgrim&#8217;s plans to boost protein conversion capacity to enhance its product offerings and minimize risk.
Over the past five years, Pilgrim&#8217;s Pride has committed huge capital to various initiatives, including more than $950 million in acquisitions, $1.8 billion in share buybacks and dividends, and $2.2 billion in capital expenditures.
Price Action: PPC shares traded higher by 5.39% at $52.98 in premarket on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/management/25/03/44301525/canadian-imperial-bank-picks-harry-culham-as-next-ceo" target="_blank" rel="noreferrer noopener">Canadian Imperial Bank Picks Harry Culham As Next CEO</a></li>
</ul>
Image via Shutterstock.

Equities

News

Dividends

Movers

General

Why Is Poultry Producer Pilgrim's Pride Stock Surging Today?

Piper Sandler analyst Korinne Wolfmeyer maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Neutral and lowers the price target from $425 to $364.

Price Target

Analyst Ratings

ULTA

Piper Sandler Maintains Neutral on Ulta Beauty, Lowers Price Target to $364

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.
<h3 class="wp-block-heading">Easterly Government Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>)</h3>
<ul>
<li>Dividend Yield: 10.33%</li>
<li>RBC Capital analyst Michael Carroll maintained an Underperform rating and cut the price target from $12 to $11 on March 10, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Truist Securities analyst Michael Lewis maintained a Hold rating and lowered the price target from $14 to $13 on Dec. 6, 2024. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: On Feb. 25, Easterly Government Props posted fourth-quarter FFO of 29 cents, in-line with estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest DEA <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="905" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119.png" alt="" class="wp-image-824364" style="width:475px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119.png 905w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119-768x710.png 768w" sizes="(max-width: 905px) 100vw, 905px" /></a></figure>
<h3 class="wp-block-heading">Park Hotels &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>)</h3>
<ul>
<li>Dividend Yield: 9.17%</li>
<li>UBS analyst Robin Farley maintained a Neutral rating and cut the price target from $15 to $13 on Feb. 3, 2025. This analyst has an accuracy rate of 80%.</li>
<li>Wolfe Research analyst Keegan Carl downgraded the stock from Outperform to Peer Perform on Sept. 26, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On Feb. 19, Park Hotels &amp; Resorts posted better-than-expected quarterly revenue.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">latest PK news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="900" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120.png" alt="" class="wp-image-824366" style="width:492px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120.png 900w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120-768x714.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></a></figure>
<h3 class="wp-block-heading">Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>)</h3>
<ul>
<li>Dividend Yield: 7.60%</li>
<li>Wedbush analyst Richard Anderson downgraded the stock from Neutral to Underperform and cut the price target from $18 to $16 on Jan. 2, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Wells Fargo analyst James Feldman assumed an Underweight rating and raised the price target from $16 to $17 on Oct. 1, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Feb. 19, Healthcare Realty Trust reported quarterly earnings of 40 cents per share.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">HR news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="845" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121.png" alt="" class="wp-image-824369" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121-768x712.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More:
<ul>
<li> <a href="https://www.benzinga.com/markets/25/03/44300558/jim-cramer-arthur-j-gallagher-is-solid-this-industrial-company-is-fantastic">Jim Cramer: Arthur J. Gallagher Is &#8216;Solid,&#8217; This Industrial Company Is &#8216;Fantastic&#8217;</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

Wall Street's Most Accurate Analysts Spotlight On 3 Real Estate Stocks Delivering High-Dividend Yields

Needham analyst Quinn Bolton reiterates D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) with a Buy and maintains $8.5 price target.

Reiteration

QBTS

Needham Reiterates Buy on D-Wave Quantum, Maintains $8.5 Price Target

Needham analyst Quinn Bolton reiterates Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Buy and maintains $54 price target.

SMTC

Needham Reiterates Buy on Semtech, Maintains $54 Price Target

Piper Sandler analyst Peter Keith maintains Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Neutral and raises the price target from $79 to $81.

Piper Sandler Maintains Neutral on Dollar Gen, Raises Price Target to $81

Piper Sandler analyst Quinton Gabrielli maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Overweight and lowers the price target from $268 to $200.

MANH

Piper Sandler Maintains Overweight on Manhattan Associates, Lowers Price Target to $200

Needham analyst Chris Pierce reiterates Blink Charging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) from Hold to Hold.

BLNK

Needham Reiterates Hold on Blink Chargingto Hold

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBIO#NASDAQ">GBIO</a>) with a Buy and maintains $8 price target.

GBIO

Needham Reiterates Buy on Generation Bio, Maintains $8 Price Target

AAOI: 92% &#x7C; <a href="https://www.benzinga.com//node/44317133">Applied Optoelectronics shares are trading higher after the company announced a warrant issuance agreement transaction with Amazon for 7,945,399 shares.</a>
&nbsp;
SMTC: 13% &#x7C; <a href="https://www.benzinga.com//node/44316016">Semtech shares are trading higher after the company reported better-than-expected Q4 financial results.</a>
&nbsp;
RBRK: 21% &#x7C; <a href="https://www.benzinga.com//node/44315877">Rubrik shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 guidance above estimates.</a>

AAOI

RBRK

Market-Moving News for March 14th

Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) reported stronger-than-expected fourth-quarter <a href="https://www.benzinga.com/quote/ulta/earnings">financial results on Thursday</a>.
Ulta Beauty reported fourth-quarter revenue of $3.49 billion, beating the consensus estimate of $3.46 billion. The specialty beauty retailer reported fourth-quarter earnings of $8.46 per share, beating analyst estimates of $7.14 per share, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
"I am incredibly optimistic about the future of Ulta Beauty, as I believe we have the right elements to drive our success — a strong business model, an ambitious long-term plan, and passionate associates who bring our brand to life for our guests every day," said Kecia Steelman, president and CEO of Ulta Beauty.
Ulta Beauty expects fiscal year 2025 revenue of $11.5 billion to $11.6 billion versus estimates of $11.67 billion, according to Benzinga Pro. The company anticipates full-year earnings of $22.50 to $22.90 per share versus estimates of $23.50 per share.
Ulta Beauty shares fell 4.5% to close at $314.47 on Thursday.
These analysts made changes to their price targets on Ulta Beauty following earnings announcement.
<ul>
<li>Morgan Stanley analyst Simeon Gutman maintained Ulta Beauty with an Overweight rating and lowered the price target from $500 to $460.</li>
<li>Telsey Advisory Group analyst Dana Telsey maintained the stock with an Outperform rating and cut the price target from $500 to $460.</li>
</ul>
Considering buying ULTA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="611" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14070950/image-122-1024x611.png" alt="" class="wp-image-824610" style="width:518px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14070950/image-122-1024x611.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14070950/image-122-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14070950/image-122-768x459.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14070950/image-122.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44323490/ulta-beauty-docusign-and-3-stocks-to-watch-heading-into-friday">Ulta Beauty, DocuSign And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

Earnings

Ulta Beauty Analysts Slash Their Forecasts After Q4 Results

Telsey Advisory Group analyst Dana Telsey maintains Torrid Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) with a Market Perform and maintains $5 price target.

CURV

Telsey Advisory Group Maintains Market Perform on Torrid Holdings, Maintains $5 Price Target

PLTR

Palantir Technologies Partners With R1 To Launch R37 AI Lab, Revolutionizing Healthcare Financial Performance With Advanced Automation Solutions

Gogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. The company reported quarterly sales of $137.799 million which beat the analyst consensus estimate of $97.352 million by 41.55 percent. This is a 40.88 percent increase over sales of $97.810 million the same period last year.

Earnings Beats

GOGO

CORRECTION: Gogo Q4 2024 Adj. EPS $0.06 Beats $0.03 Estimate, Sales $137.799M Beat $97.352M Estimate

Needham analyst Chris Pierce maintains Urgently (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULY#NASDAQ">ULY</a>) with a Buy and lowers the price target from $1.5 to $1.

Needham Maintains Buy on Urgently, Lowers Price Target to $1

Bristol Myers Squibb Says European Commission Granted Approval To Breyanzi For Treatment Of Adult Patients With Relapsed Or Refractory Follicular Lymphoma

Wayfair Announces Plans For Second Large-Format Store In Atlanta, Set To Open In 2026, Offering 150,000 Square Feet Of Home Furniture And Decor

Telsey Advisory Group analyst Joseph Feldman maintains Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) with a Outperform and maintains $250 price target.

Telsey Advisory Group Maintains Outperform on Dick's Sporting Goods, Maintains $250 Price Target

IRIX

Iridex Says Not Aware Of Any Material Developments Or Changes To Operating Or Financial Condition For Recent Stock Price Volatility

Inspira Technologies Oxy BHN Ltd Ordinary Shares

Comments

KSB SE & Co

KSB SE & Co (KSVRF) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL